Skip to main content
. 2023 Oct 18;21:100242. doi: 10.1016/j.wnsx.2023.100242

Table 4.

Baseline comorbidities of matched CDR versus ACDF cohorts.

Comorbidities CDR ACDF p
 AIDS/HIV, n (%) a a 1.00
 Alcohol Abuse, n (%) 14 (0.8) 21 (1.1) 0.308
 Carotid Artery Disease, n (%) 29 (1.6) 25 (1.4) 0.681
 Congestive Heart Failure, n (%) a a 0.627
 Coagulopathy, n (%) a 11 (0.6) 0.823
 Chronic Pulmonary Disease, n (%) 210 (11.4) 218 (11.8) 0.719
 Deficiency Anemia, n (%) a a 0.422
 Depression, n (%) 224 (12.1) 227 (12.3) 0.920
 Diabetes (complicated), n (%) 25 (1.4) 20 (1.1) 0.549
 Diabetes (uncomplicated), n (%) 140 (7.6) 127 (6.9) 0.446
 Drug Abuse, n (%) 26 (1.4) 55 (3.0) 0.002
 Fluid and Electrolyte Disorders, n (%) 11 (0.6) 21 (1.4) 0.110
 Hypertension (complicated), n (%) 16 (0.9) a 0.054
 Hypertension (uncomplicated), n (%) 458 (24.8) 460 (24.9) 0.970
 Hypothyroidism, n (%) 113 (6.1) 107 (5.8) 0.728
 Liver Disease, n (%) 16 (0.9) a 0.054
 Obesity, n (%) 199 (10.8) 187 (10.1) 0.554
 Other Neurologic Disorder, n (%) 34 (1.8) 46 (2.5) 0.214
 Paralysis, n (%) a 11 (0.6) 0.210
 Pulmonary Circulation Disorders, n (%) a a 1.00
 Peripheral Vascular Disorders, n (%) a 16 (0.9) 0.094
 Renal Failure, n (%) 16 (0.9) a 0.152
 Rheumatoid Arthritis, n (%) 27 (1.5) 20 (1.1) 0.378
 Valvular Disease, n (%) 14 (0.8) a 0.403
Elixhauser Comorbidity Index
 Elixhauser Score, mean (SD) 0.88 (1.11) 0.89 (1.08) 0.845
a

Value is below NRD reporting minimum of 10 or fewer cases.